Many people regain weight after stopping, which is why ongoing treatment is often recommended
It could be attributed to the fact that the method through which Tirzepatide affects the "nausea center" in the brain is somewhat different than just acting through the GLP-1 pathway
This can be done orally, topically, intravenously, intranasally, or in nebulised form
Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target
Conclusion GLP-1 receptor agonists have emerged as essential tools in cardiovascular medicine, transcending their original purpose as antihyperglycemic agents
Necrotizing enterocolitis in a dutch cohort of very preterm infants: prevalence, mortality, and long-term outcomes